A. Aklian

Most-cited papers

1. Receptor Tyrosine Kinases Activate Canonical WNT/β-Catenin Signaling via MAP Kinase/LRP6 Pathway and Direct β-Catenin Phosphorylation

   P. Krejci, A. Aklian, M. Kaucká, Eva Ševčíková +16 more

   2012PLoS ONE160 citations Open access

   Semantic Scholar

   Save

2. Fibroblast growth factor and canonical WNT/β-catenin signaling cooperate in suppression of chondrocyte differentiation in experimental models of FGFR signaling in cartilage.

   M. Buchtová, V. Oralová, A. Aklian, Jan Mašek +18 more

   2015Biochimica et Biophysica Acta61 citations Open access

   Semantic Scholar

   Save

3. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence

   P. Krejci, J. Procházková, Jiri Smutny, Katarina Chlebová +5 more

   2010Bone57 citations Open access

   Semantic Scholar

   Save

4. NF449 Is a Novel Inhibitor of Fibroblast Growth Factor Receptor 3 (FGFR3) Signaling Active in Chondrocytes and Multiple Myeloma Cells*

   P. Krejci, S. Murakami, J. Procházková, L. Trantírek +7 more

   2010Journal of Biological Chemistry38 citations Open access

   Semantic Scholar

   Save

5. [Spontaneous cerebrospinal rhinorrhea in patients with parasellar tumor].

   B. I. Dunaĭvitser, R. M. Khanamirian, M. A. Grigorian, A. Aklian

   1977Zhurnal ushnykh, nosovykh i gorlovykh boleznei = The journal of otology, rhinology, and laryngologie [sic]0 citations

   Semantic Scholar

   Save

6. is a novel inhibitor of fibroblast growth factor receptor 3 (FGFR3) signaling active in chondrocytes and multiple myeloma cells

   PavelKrejci, S. Murakami, Jiřina Procházková, L. Trantírek +7 more

   0 citations

   Semantic Scholar

   Save